BHVN Q4 2021 Earnings — Biohaven Ltd. Revenue & Financial Results | Market Cap Arena

BHVNBiohaven Ltd.

$1B

Q4 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0-100.0% YoY

Gross Profit

$0

Operating Income

-$51M

Net Income

-$52M

EPS (Diluted)

$-1.45

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$33M

Free Cash Flow

-$33M

Stock-Based Comp.

$13M

Balance Sheet

Total Assets

$142M

Total Liabilities

$47M

Stockholders' Equity

$35M

Cash & Equivalents

$76M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$35M	-100.0%
Gross Profit	$0	$25M	-100.0%
Operating Income	-$51M	-$171M	+70.2%
Net Income	-$52M	-$218M	+76.2%